SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-025877
Filing Date
2022-11-30
Accepted
2022-11-30 16:32:38
Documents
13
Period of Report
2022-11-30
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sqz-20221130.htm   iXBRL 8-K 78796
2 EX-99.1 sqz-ex99_1.htm EX-99.1 25594
  Complete submission text file 0000950170-22-025877.txt   239127

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sqz-20221130_lab.xml EX-101.LAB 14572
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sqz-20221130.xsd EX-101.SCH 2460
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sqz-20221130_pre.xml EX-101.PRE 10672
7 EXTRACTED XBRL INSTANCE DOCUMENT sqz-20221130_htm.xml XML 5107
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Filer) CIK: 0001604477 (see all company filings)

IRS No.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39662 | Film No.: 221435985
SIC: 2836 Biological Products, (No Diagnostic Substances)